CY1110670T1 - Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων - Google Patents

Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων

Info

Publication number
CY1110670T1
CY1110670T1 CY20101100677T CY101100677T CY1110670T1 CY 1110670 T1 CY1110670 T1 CY 1110670T1 CY 20101100677 T CY20101100677 T CY 20101100677T CY 101100677 T CY101100677 T CY 101100677T CY 1110670 T1 CY1110670 T1 CY 1110670T1
Authority
CY
Cyprus
Prior art keywords
interest
secretion
homogeneity
relates
improvement
Prior art date
Application number
CY20101100677T
Other languages
English (en)
Inventor
Hagit Amitai
Edith Chitlaru
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of CY1110670T1 publication Critical patent/CY1110670T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα ευρεσιτεχνία σχετίζεται με μία μέθοδο για την βελτίωση της ομογένειας και/ ή έκκρισης μία ανασυνδυασμένης πρωτεΐνης ενδιαφέροντος που εκφράζεται σε κύτταρα θηλαστικών, αντικαθιστώντας την ενδογενή σηματοδοτική αλληλουχία πεπτιδίων του DNA που κωδικοποιεί την πρωτεΐνη ενδιαφέροντος με την ανθρώπινη hGH. Η ευρεσιτεχνία επίσης σχετίζεται με τους φορείς έκφρασης του DNA, που περιέχουν την αλληλουχία που σηματοδοτεί τέτοιες πρωτεΐνες, οι οποίες συντήκονται στην αλληλουχία σήματος πεπτιδίων της hGH και σε κύτταρα που φιλοξενούν τέτοιους φορείς.
CY20101100677T 2000-12-05 2010-07-20 Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων CY1110670T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL14011000A IL140110A0 (en) 2000-12-05 2000-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
EP01999652A EP1339855B1 (en) 2000-12-05 2001-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems

Publications (1)

Publication Number Publication Date
CY1110670T1 true CY1110670T1 (el) 2015-06-10

Family

ID=11074884

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100677T CY1110670T1 (el) 2000-12-05 2010-07-20 Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων

Country Status (14)

Country Link
US (2) US20040115775A1 (el)
EP (1) EP1339855B1 (el)
JP (1) JP2004516830A (el)
AT (1) ATE471986T1 (el)
AU (2) AU2245402A (el)
CA (1) CA2429094A1 (el)
CY (1) CY1110670T1 (el)
DE (1) DE60142446D1 (el)
DK (1) DK1339855T3 (el)
ES (1) ES2346956T3 (el)
IL (1) IL140110A0 (el)
PT (1) PT1339855E (el)
SI (1) SI1339855T1 (el)
WO (1) WO2002046430A2 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2479942T3 (es) * 2003-04-18 2014-07-25 Biogen Idec Ma Inc. Neublastina glucosilada conjugada con polímero
GB0314856D0 (en) 2003-06-25 2003-07-30 Unitargeting Res As Protein expression system
CA2537340A1 (en) 2003-09-26 2005-04-07 Applied Research Systems Ars Holding N.V. Leader sequences for use in production of proteins
US7598059B2 (en) 2003-10-02 2009-10-06 Biogen Idec Ma Inc. Neublastin expression constructs
AU2005277227B2 (en) 2004-08-19 2011-10-06 Biogen Ma Inc. Refolding transforming growth factor beta family proteins
PL1885753T3 (pl) * 2005-06-03 2011-12-30 Ares Trading Sa Wytwarzanie rekombinowanego białka wiążącego IL-18
EP1902126A1 (en) * 2005-07-12 2008-03-26 Codon Devices, Inc Compositions and methods for biocatalytic engineering
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
WO2008108344A1 (ja) * 2007-03-02 2008-09-12 Cellgentech, Inc. Lcat欠損症の遺伝子治療用細胞並びにこれを産生するのに用いられる複製欠損性レトロウイルスベクター及びプラスミド
JP5583005B2 (ja) 2007-05-01 2014-09-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド 血管新生を増大させるための組成物および方法
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
WO2010036978A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
US9150880B2 (en) 2008-09-25 2015-10-06 Proteovec Holding, L.L.C. Vectors for production of antibodies
EP2417263B1 (en) 2009-04-09 2015-09-23 ProteoVec Holding L.L.C. Production of proteins using transposon-based vectors
AU2014225272B2 (en) 2013-03-08 2015-10-22 Neuclone Biologics Pty Ltd A cell expression system
EA201591293A1 (ru) * 2013-03-14 2016-02-29 Шир Хьюман Дженетик Терапис, Инк. Способы и композиции для доставки антител, кодируемых мрнк
WO2016154344A1 (en) 2015-03-24 2016-09-29 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
CN111304243A (zh) * 2018-12-12 2020-06-19 普莱柯生物工程股份有限公司 一种高效表达外源蛋白的cho细胞株的构建方法、构建的cho细胞株及其应用
CN114746556A (zh) * 2019-07-18 2022-07-12 利索基因公司 用于治疗山菲立普病和其他障碍的组合物和方法
WO2022042673A1 (zh) * 2020-08-28 2022-03-03 江苏恒瑞医药股份有限公司 用于降低异源多肽末端异质性的信号肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
US5417970A (en) * 1988-10-21 1995-05-23 Sanofi Drugs containing a glycosylated interleukin-2
HU230275B1 (hu) * 1996-09-13 2015-11-30 Shire Human Genetic Therapies, Inc Eljárás tisztított humán alfa-galaktozidáz-A készítmények előállítására, és a tisztított készítményeket tartalmazó gyógyászati készítmények, alfa-gal-A-deficienciából eredő rendellenességek kezelésében történő alkalmazásra
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii

Also Published As

Publication number Publication date
DK1339855T3 (da) 2010-08-30
JP2004516830A (ja) 2004-06-10
SI1339855T1 (sl) 2010-08-31
WO2002046430A2 (en) 2002-06-13
WO2002046430A3 (en) 2003-01-03
CA2429094A1 (en) 2002-06-13
AU2245402A (en) 2002-06-18
AU2002222454B2 (en) 2007-04-05
US20060234352A1 (en) 2006-10-19
EP1339855B1 (en) 2010-06-23
US20040115775A1 (en) 2004-06-17
DE60142446D1 (de) 2010-08-05
EP1339855A2 (en) 2003-09-03
US7282352B2 (en) 2007-10-16
ATE471986T1 (de) 2010-07-15
ES2346956T3 (es) 2010-10-22
IL140110A0 (en) 2002-02-10
PT1339855E (pt) 2010-07-07

Similar Documents

Publication Publication Date Title
CY1110670T1 (el) Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων
WO2005017149A8 (en) Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
NZ232742A (en) Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
ATE49233T1 (de) Vektoren zur transformation von hefe.
DK0531404T3 (da) Ubiquitin-specifik protease
ATE424457T1 (de) Menschliche stra6 polypeptide
AR012499A1 (es) Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin
Canova-Davis et al. Transpeptidation during the analytical proteolysis of proteins
ATE317443T1 (de) N-terminal verlängerte proteine exprimiert in hefe
ATE284443T1 (de) Rekombinantes aktives humänes zona pellucida protein 3 (hzp3)
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
NO178504C (no) Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat
DK1241179T3 (da) Humant protein med in vitro antiproliferativ aktivitet.
HK1065067A1 (en) Cdna encoding the human alpha2 delta4 calcium channel subunit
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
MX2024001179A (es) Proteinas de union a antigenos que se unen especificamente a ct45.
DK1241186T4 (da) Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor
DE69943058D1 (de) Loslösendes protein 5 - ucp5
DK1241251T3 (da) Humant prostasin-lignende protein og nukleinsyrer kodende for samme
DK1241180T3 (da) Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
DK1241184T3 (da) Humant synaptogyrin-lignende protein og nukleinsyrer kodende for dette
ECSP993285A (es) Sintesis recombinante de beta lipotropina y otros peptidos
WO2002024913A3 (en) 32612, a novel human peptide transporter and uses therefor